1. Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction. (25th November 2020) Authors: Bruckert, C; Remila, L; Matsushita, K; Auger, C; Houngue, U; Chaker, A; Park, S; Algara-Suarez, P; Belcastro, E; Jesel, L; Ohlmann, P; Morel, O; Schini-Kerth, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗